Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 16/20 | 0.66 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.56 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.56 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.56 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.56 |
| ▸ | SMO | Q99835 | 1/20 | 0.52 |
| ▸ | RAF1 | P04049 | 3/20 | 0.52 |
| ▸ | BRAF | P15056 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6976106 | 0.92 | MAPK14 (0.60) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL6980605 | 0.89 | MAPK14 (0.59) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL6974083 | 0.88 | MAPK14 (0.59) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL6979962 | 0.87 | MAPK14 (0.61) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL6476055 | 0.86 | MAPK14 (0.67) | MAPK14SMO | |
| SCHEMBL6224722 | 0.85 | MAPK14 (0.85) | MAPK14RAF1BRAF | |
| SCHEMBL6972715 | 0.85 | MAPK14 (0.52) | MAPK14SMORAF1BRAF | |
| SCHEMBL7828018 | 0.84 | MAPK14 (0.59) | MAPK14RAF1BRAF | |
| SCHEMBL6978609 | 0.81 | MAPK14 (0.68) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL7835408 | 0.81 | MAPK14 (0.63) | MAPK14MAPK13RAF1BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1115707-B1 | BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS | ASTRAZENECA AB (SE) | 2003-11-12 | — | — | EP | disclosed |
| US-6455520-B1 | TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS | ASTRA ZENECA AB (SE) | 2002-09-24 | — | — | US | disclosed |
| EP-1115707-A1 | BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS | AstraZeneca AB (SE) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000018738-A1 | BENZAMIDE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS | ASTRAZENECA AB (SE) | 2000-04-06 | — | — | WO | disclosed |